bioLIVE to introduce global biopharma country ranking

Global analysis will rank each major biomanufacturing country’s market growth potential, innovation and competitiveness

picture of

Breaking News

Wacker strengthens its pharmaceutical-protein business and buys Dutch biotech plant

Wacker Chemie AG has acquired a Dutch site to manufacture biopharmaceuticals, live microbial products and vaccines, ...

Sartorius Stedim Biotech and Penn State University announce partnership

Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance ...

Almac Diagnostics validates Illumina TruSight Tumor 170 cancer mutation panel clinical trials

The Almac Illumina TruSight Tumor 170 Clinical Trial Assay is a Next Generation Sequencing (NGS) assay for use with ...

Biopharma boom brings benefits to CROs

The analytical outsourcing sector is well placed to benefit from the continuing rise in biopharmaceutical manufacturing

GSK signs strategic agreement to transfer rare disease gene therapy portfolio to Orchard Therapeutics

Agreement strengthens Orchard’s position as a global leader in gene therapy for rare diseases

Transgene and Randox to develop innovative multifunctional oncolytic virotherapies for solid tumors

Novel oncolytic virotherapies will be developed by Transgene, based on its next generation Invir.IO Platform and ...

Performance validation: HPAPI containment testing in a risk-based era

Taking a more automated approach to validation testing paves the way to capturing more repeatable and reliable data, ...

Bionical Group announces bionical-clinical early access programmes (EAP)

Early Access Programmes (often called Pre-approval Access, Compassionate Use, Named Patient, Expanded Access, Managed ...

Quay establishes biotherapeutic GMP suites

The UK based pharmaceutical outsourcing specialist continues to invest in its work in live biotherapeutics at its ...

Gene transfer therapy approved for the treatment of ALL: part II

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

Gene transfer therapy approved for the treatment of ALL: part I

In August 2017, Novartis received FDA approval for its chimeric antigen receptor T (CAR-T) cell therapy, Kymriah, for ...

Regenerative medicine and the benefits of cell-based combinatorial screening technology

Although many technical challenges remain ahead, regenerative medicine has the potential to profoundly change the way ...

Evidence supporting infliximab biosimilar use in Crohns

According to GlobalData, real-world evidence supporting infliximab biosimilar use in Crohn’s disease will boost the ...

UK pharma and biotech patent filings surge, investor confidence sign?

The European Patent Office has reported a surge in pharmaceutical and biotechnology patents – potentially a sign of ...